About CivaTech Oncology
CivaTech Oncology is a company based in Durham (United States) founded in 2006.. CivaTech Oncology has raised $12.4 million across 18 funding rounds from investors including NIH, HHS and National Cancer Institute. CivaTech Oncology offers products and services including CivaSheet, CivaString, and CivaDerm. CivaTech Oncology operates in a competitive market with competitors including Koya Medical, Sensus Healthcare, Theragenics, Eckert & Ziegler BEBIG and C4 Imaging, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Civatech Oncology Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.4 M (USD)
in 18 rounds
-
Latest Funding Round
$7.94 M (USD), Series A
Nov 19, 2021
-
Investors
NIH
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CivaTech Oncology
CivaTech Oncology offers a comprehensive portfolio of products and services, including CivaSheet, CivaString, and CivaDerm. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Flexible, bioabsorbable source for planar radiation in cancer treatment.
Linear source for treating localized solid tumors effectively.
Temporary product for intraoperative skin cancer radiation therapy.
Unlock access to complete
Unlock access to complete
Funding Insights of CivaTech Oncology
CivaTech Oncology has successfully raised a total of $12.4M across 18 strategic funding rounds. The most recent funding activity was a Series A round of $7.94 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 18
- Last Round Series A — $7.9M
-
First Round
First Round
(26 Jun 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series A - CivaTech Oncology | Valuation |
investors |
|
| Apr, 2021 | Amount | Grant - CivaTech Oncology | Valuation |
investors |
|
| Dec, 2017 | Amount | Debt – Conventional - CivaTech Oncology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CivaTech Oncology
CivaTech Oncology has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and National Cancer Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Cancer research is conducted and supported by the institute.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CivaTech Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CivaTech Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Civatech Oncology Comparisons
Competitors of CivaTech Oncology
CivaTech Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Koya Medical, Sensus Healthcare, Theragenics, Eckert & Ziegler BEBIG and C4 Imaging, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of smart wearable compression technology for lymphedema and venous diseases
|
|
| domain | founded_year | HQ Location |
Non-invasive skin cancer treatments are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Manufacturer of surgical products and brachytherapy devices
|
|
| domain | founded_year | HQ Location |
Brachytherapy devices are developed for prostate, breast, and gynecological cancers.
|
|
| domain | founded_year | HQ Location |
Image-guided procedures for prostate cancer treatment are provided.
|
|
| domain | founded_year | HQ Location |
Breast microseed radiotherapy for early-stage breast cancer is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Civatech Oncology
Frequently Asked Questions about CivaTech Oncology
When was CivaTech Oncology founded?
CivaTech Oncology was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is CivaTech Oncology located?
CivaTech Oncology is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Is CivaTech Oncology a funded company?
CivaTech Oncology is a funded company, having raised a total of $12.4M across 18 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $15K, raised on Jun 26, 2007.
What does CivaTech Oncology do?
CivaTech Oncology was founded in 2006 in Durham, United States, and operates in the oncology sector. Polymer-based devices for localized low-dose-rate brachytherapy are developed and supplied to treat solid tumors. Key products include CivaString, a linear polymer-encapsulated source, and CivaSheet, an implantable membrane-like device, both used for targeted radiation delivery in clinical settings.
Who are the top competitors of CivaTech Oncology?
CivaTech Oncology's top competitors include Koya Medical, Sensus Healthcare and RadioGel.
What products or services does CivaTech Oncology offer?
CivaTech Oncology offers CivaSheet, CivaString, and CivaDerm.
Who are CivaTech Oncology's investors?
CivaTech Oncology has 3 investors. Key investors include NIH, HHS, and National Cancer Institute.